Skip To Main Content
US Healthcare Professionals Site

ACTEMRA® (tocilizumab)‎ ALECENSA® (alectinib) Avastin® (bevacizumab) COLUMVI™ (glofitamab-gxbm) COTELLIC® (cobimetinib) ENSPRYNG® (satralizumab-mwge) Erivedge® (vismodegib) Evrysdi® (risdiplam) GAZYVA® (obinutuzumab) HEMLIBRA® (emicizumab-kxwh) Herceptin® (trastuzumab) Herceptin HYLECTA® (trastuzumab and hyaluronidase-oysk) Itovebi™ (inavolisib) KADCYLA® (ado-trastuzumab emtansine) LUCENTIS® (ranibizumab injection) LUNSUMIO™ (mosunetuzumab-axgb) OCREVUS® (ocrelizumab) and OCREVUS ZUNOVO™ (ocrelizumab & hyaluronidase-ocsq) PERJETA® (pertuzumab) PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) PiaSky™ (crovalimab-akkz) POLIVY® (polatuzumab vedotin-piiq) Pulmozyme® (dornase alfa) Inhalation Solution Rituxan® (rituximab) for Rheumatoid Arthritis (RA) RITUXAN® (rituximab) for Oncology Rituxan® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV) RITUXAN HYCELA® (rituximab/hyaluronidase human) ROZLYTREK® (entrectinib) SUSVIMO™ (ranibizumab injection) TECENTRIQ® (atezolizumab) TECENTRIQ HYBREZA™ (atezolizumab and hyaluronidase-tqjs) VABYSMO® (faricimab-svoa) VENCLEXTA® (venetoclax tablets) XOLAIR® (omalizumab) for subcutaneous use ZELBORAF® (vemurafenib) Oncology Ophthalmology Rheumatology

ACTEMRA® (tocilizumab)‎ ALECENSA® (alectinib) Avastin® (bevacizumab) COLUMVI™ (glofitamab-gxbm) COTELLIC® (cobimetinib) ENSPRYNG® (satralizumab-mwge) Erivedge® (vismodegib) Evrysdi® (risdiplam) GAZYVA® (obinutuzumab) HEMLIBRA® (emicizumab-kxwh) Herceptin® (trastuzumab) Herceptin HYLECTA® (trastuzumab and hyaluronidase-oysk) Itovebi™ (inavolisib) KADCYLA® (ado-trastuzumab emtansine) LUCENTIS® (ranibizumab injection) LUNSUMIO™ (mosunetuzumab-axgb) OCREVUS® (ocrelizumab) and OCREVUS ZUNOVO™ (ocrelizumab & hyaluronidase-ocsq) PERJETA® (pertuzumab) PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) PiaSky™ (crovalimab-akkz) POLIVY® (polatuzumab vedotin-piiq) Pulmozyme® (dornase alfa) Inhalation Solution Rituxan® (rituximab) for Rheumatoid Arthritis (RA) RITUXAN® (rituximab) for Oncology Rituxan® (rituximab) for Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV) RITUXAN HYCELA® (rituximab/hyaluronidase human) ROZLYTREK® (entrectinib) SUSVIMO™ (ranibizumab injection) TECENTRIQ® (atezolizumab) TECENTRIQ HYBREZA™ (atezolizumab and hyaluronidase-tqjs) VABYSMO® (faricimab-svoa) VENCLEXTA® (venetoclax tablets) XOLAIR® (omalizumab) for subcutaneous use ZELBORAF® (vemurafenib) Oncology Ophthalmology Rheumatology

How Can We Help You?

There may be options to help you afford your Genentech medicine, no matter what type of health insurance you have.

Patient with Laptop

If you have commercial health insurance and meet other eligibility criteria, the ACTEMRA Co-pay Program may be able to help you pay for your medicine.

Learn more
Young family in office

If you have public insurance or commercial insurance, ACTEMRA Access Solutions can refer you to an independent co-pay assistance foundation that might help pay for your Genentech medicine.

Learn more
Older couple holding hands

If you don’t have health insurance coverage or have financial concerns and meet eligibility criteria, you may be able to get free medicine from the Genentech Patient Foundation.

Learn more
Patient with Laptop

The ACTEMRA Co-pay Program

The ACTEMRA Co-pay Program can help you with the out-of-pocket costs for your Genentech medicine, if you’re eligible.

The ACTEMRA Co-pay Program helps patients with commercial health insurance. This might be a plan you get through your employer or one you purchased through a Health Insurance Marketplace. To qualify, you must also meet other criteria.

Learn More

Eligibility criteria apply. Not valid for patients using federal or state government programs to pay for their Genentech medicine. Patients must be taking the Genentech medicine for an FDA-approved indication. Please visit the Co-pay Program website for the full list of Terms and Conditions.

child coloring at office

Referrals to Independent Co-pay Assistance Foundations

If you need help with the co-pay for your Genentech medicine, ACTEMRA Access Solutions can refer you to an independent co-pay assistance foundation.

An independent co-pay assistance foundation is a charitable organization that gives financial assistance for medicines.

Call ACTEMRA Access Solutions at (866) 681-3261 for a referral.

These foundations may be able to help you. Please check their websites for up-to-date information.

Patient Access Network Foundation (PANF)

The Assistance Fund, Inc.

Patient Advocate Foundation (PAF)

The HealthWell Foundation

At this time, no independent co-pay assistance foundations have been identified. Please call ACTEMRA Access Solutions at (866) 681-3261 for assistance.

Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help you. We can only refer you to a foundation that supports your disease state. This information is provided as a resource for you. Genentech does not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help you.

Older couple holding hands

The Genentech Patient Foundation

The Genentech Patient Foundation gives free Genentech medicine to people who meet income guidelines and:

  • Who don’t have health insurance
  • Whose treatment is not covered by health insurance
  • Whose treatment is covered by health insurance and have an out-of-pocket maximum that is more than 7.5% of their household income

To learn more and to apply for help, visit GenentechPatientFoundation.com.

This program is intended to assist patients who are living in the United States and are being treated by a US-licensed physician. We do not collect or require citizenship information.

Patients whose health insurance plan or employer requires them to go through a third-party Alternative Funding Program (AFP) and apply to the Genentech Patient Foundation as a condition of, requirement for, or prerequisite to coverage of a Genentech medicine will not be eligible for assistance from the Genentech Patient Foundation. AFPs may pose potential risks to patients by interfering with their receiving timely treatment and burdening patients with undue stress when trying to access prescribed medicines.

If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech medicine, you must meet a different set of income requirements. 

Genentech reserves the right to modify or discontinue the program at any time and to verify the accuracy of information submitted.

How to Work With ACTEMRA Access Solutions

ACTEMRA Access Solutions offers support in many different languages and teletypewriter (TTY) services.

Need assistance?

patient consent form icon

Enroll in ACTEMRA Access Solutions.

How do I enroll?

Phone Icon

We work with you, your doctor’s office, your health insurance plan and your specialty pharmacy. We might contact you for more information.

What will we find out?

patient icon

We refer you to financial assistance options.

What options are there?

    • You fill out the Patient Consent Form

    • Your doctor fills out the Prescriber Service Form. You do not have to fill out anything on this form

    • Your doctor sends both of these forms to ACTEMRA Access Solutions

  • We can find out if your health insurance plan covers your Genentech medicine and how much your out-of-pocket costs will be.

  • If you need help paying for your Genentech medicine, there may be options for assistance. You can find out more about these options by scrolling up on this page.